These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33740880)

  • 21. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shear-dependent platelet aggregation size.
    Chan CHH; Inoue M; Ki KK; Murashige T; Fraser JF; Simmonds MJ; Tansley GD; Watanabe N
    Artif Organs; 2020 Dec; 44(12):1286-1295. PubMed ID: 32735693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.
    Dassanayaka S; Slaughter MS; Bartoli CR
    ASAIO J; 2013; 59(2):123-9. PubMed ID: 23438773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.
    Vincent F; Rauch A; Loobuyck V; Robin E; Nix C; Vincentelli A; Smadja DM; Leprince P; Amour J; Lemesle G; Spillemaeker H; Debry N; Latremouille C; Jansen P; Capel A; Moussa M; Rousse N; Schurtz G; Delhaye C; Paris C; Jeanpierre E; Dupont A; Corseaux D; Rosa M; Sottejeau Y; Barth S; Mourran C; Gomane V; Coisne A; Richardson M; Caron C; Preda C; Ung A; Carpentier A; Hubert T; Denis C; Staels B; Lenting PJ; Van Belle E; Susen S
    J Am Coll Cardiol; 2018 May; 71(19):2106-2118. PubMed ID: 29747831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of flow-induced hemolysis using novel Couette-type blood-shearing devices.
    Zhang T; Taskin ME; Fang HB; Pampori A; Jarvik R; Griffith BP; Wu ZJ
    Artif Organs; 2011 Dec; 35(12):1180-6. PubMed ID: 21810113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation into the effect of the aspect ratio of cylindrical surface microstructure on von Willebrand factor damage.
    Mei X; Zhang L; Zhu Y
    Int J Artif Organs; 2022 Mar; 45(3):322-330. PubMed ID: 35075935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.
    Coghill PA; Kanchi S; Azartash-Namin ZJ; Long JW; Snyder TA
    ASAIO J; 2019 Jul; 65(5):481-488. PubMed ID: 30004942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A CFD-based Kriging surrogate modeling approach for predicting device-specific hemolysis power law coefficients in blood-contacting medical devices.
    Craven BA; Aycock KI; Herbertson LH; Malinauskas RA
    Biomech Model Mechanobiol; 2019 Aug; 18(4):1005-1030. PubMed ID: 30815758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices.
    Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.
    Selgrade BP; Truskey GA
    Artif Organs; 2012 Apr; 36(4):E89-96. PubMed ID: 22360826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study.
    Chan CHH; Diab S; Moody K; Frazier OH; Sampaio LC; Fraser CD; Teruya J; Adachi I
    Artif Organs; 2018 Nov; 42(11):1028-1034. PubMed ID: 30101559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of blood viscosity on shear-induced hemolysis using a magnetically levitated shearing device.
    Krisher JA; Malinauskas RA; Day SW
    Artif Organs; 2022 Jun; 46(6):1027-1039. PubMed ID: 35030287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the universality of the hemolysis power law model from simulations of the FDA nozzle using calibrated model coefficients.
    Mantegazza A; Tobin N; Manning KB; Craven BA
    Biomech Model Mechanobiol; 2023 Apr; 22(2):433-451. PubMed ID: 36418603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.